Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis.

Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou J P, Anegon I

Institut National de la Santé et de la Recherche Médicale (INSERM U211), Nantes, France.

Transplant Proc. 1995 Feb;27(1):336-7.

Abstract

摘要

相似文献

Transplant Proc. 1995 Feb;27(1):336-7.

Transplant Proc. 1995 Feb;27(1):328-9.

Transplant Proc. 1995 Feb;27(1):330.

Transplant Proc. 1995 Feb;27(1):321-3.

Eur J Immunol. 1992 Dec;22(12):3135-40. doi: 10.1002/eji.1830221216.

Transplantation. 1994 Dec 15;58(11):1222-9.

Lab Invest. 1994 Jun;70(6):830-5.

Trans Assoc Am Physicians. 1991;104:164-72.

Transplant Proc. 1995 Feb;27(1):333-5.

Lab Invest. 1996 Jun;74(6):1039-49.

Immunology. 1997 Apr;90(4):640-6. doi: 10.1046/j.1365-2567.1997.00200.x.

Clin Exp Immunol. 1995 Dec;102(3):589-95. doi: 10.1111/j.1365-2249.1995.tb03857.x.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。